Guillain-Barré Syndrome Following the First Dose of Inactivated SARS-CoV-2 Vaccine, BBIBP-CorV.
| Autor: | Wijekoon L; Department of Medicine, Rajarata University of Sri Lanka, Anuradhapura, LKA., Sarathchandra C; Department of Medicine, Rajarata University of Sri Lanka, Anuradhapura, LKA., Siribaddana S; Department of Medicine, Rajarata University of Sri Lanka, Anuradhapura, LKA. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Cureus [Cureus] 2023 Jan 18; Vol. 15 (1), pp. e33952. Date of Electronic Publication: 2023 Jan 18 (Print Publication: 2023). |
| DOI: | 10.7759/cureus.33952 |
| Abstrakt: | We present a case report of Guillain-Barré syndrome (GBS) following inactivated whole virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine, BBIBP-CorV. A man presented with paresthesia in both upper and lower limbs with bifacial weakness, onset 18 days after receiving the first BBIBP-CorV vaccine. A bifacial palsy with a paresthesia variant of GBS was diagnosed, and the patient was treated with intravenous immunoglobulin, arresting the progression of neurological symptoms. Clinicians need to be aware of the possibility of GBS following vaccination with BBIBP-CorV, an inactivated SARS-CoV-2 vaccine. Competing Interests: The authors have declared that no competing interests exist. (Copyright © 2023, Wijekoon et al.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|